US 11584736
Heterocyclic P2Y14 receptor antagonists
granted A61PA61P11/06A61P13/12
Quick answer
US patent 11584736 (Heterocyclic P2Y14 receptor antagonists) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P11/06, A61P13/12, A61P29/00